Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

With limited severe acute respiratory syndrome coronavirus (SARS-CoV-2) testing capacity in the United States at the start of the epidemic (January March 2020), testing was focused on symptomatic patients with a travel history throughout February, obscuring the picture of SARS-CoV-2 seeding and comm...

Full description

Bibliographic Details
Main Authors: Althoff, K.N (Author), Anton-Culver, H. (Author), Cherry, J. (Author), Cicek, M.S (Author), Denny, J.C (Author), Gebo, K.A (Author), Goldstein, D. (Author), Havers, F.P (Author), Karlson, E.W (Author), Kouame, A. (Author), Lowy, D. (Author), Malin, B.A (Author), Ohno-Machado, L. (Author), Pinto, L.A (Author), Ramirez, A. (Author), Roman, A. (Author), Schlueter, D.J (Author), Schully, S.D (Author), Sharpless, N.E (Author), Thibodeau, S.N (Author), Thomsen, I. (Author), Williams, C. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
All of Us Research Program
Antibodies, Viral
COVID-19
diagnosis
enzyme linked immunosorbent assay
Enzyme-Linked Immunosorbent Assay
Epidemic
human
Humans
immunoglobulin G
Immunoglobulin G
Immunoglobulin G antibodies
population health
Population Health
SARS-CoV-2
sensitivity and specificity
Sensitivity and Specificity
United States
virus antibody
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items